Message Font: Serif | Sans-Serif
No. of Recommendations: 0
with recent drug trials comming up negative my concern is gilead going forward.Do they have sufficiant revenue and pipeline to justify continued investment.Is this recent dip a buying opportunity ?
Print the post Back To Top
No. of Recommendations: 0
The company just got a set back.....that's why the
stock came down from $56 to about $44. But I think
it has plenty of cash..... and hte sales are doing

How lower the stock could go I do not know....but
if dips below $40... I would be a net buyer.

I have owned the stock since 2002!

The Eternal Bird.
Print the post Back To Top